$SMTC

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Semtech (SMTC) expects Q2 revenue of $328M, up 27% YoY, and EPS of $0.61. Shares fell 21.6% last week despite a 137% one-year gain. Demand for GaN chips is outpacing supply, with Semtech planning to double or triple capacity.

Original reporting
Published Aug 25, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher? — source image
Decision brief

The 30-second read

$SMTCBullishMed
01

Why it matters

The new guidance may reverse recent sell pressure and attract growth investors.

02

Market read

Guidance highlights strong GaN demand, influencing semiconductor sector sentiment.

03

What to watch

Potential supply chain bottlenecks and competition from rivals.

Relevance 8/10Novelty 8/10Timing: pre‑market tonight

Background

Semtech's guidance follows a 21.6% share decline last week despite a 137% YTD rally.

Company-level read

Ticker impact

$SMTCBullishHigh confidence
Context

Semtech reported Q2 revenue of $328M (+27% YoY) and EPS of $0.61, its first guidance release for the quarter.

Expected impact

Potential upside of 5-8% if market digests the beat.

Evidence & confidence

Revenue growth and EPS beat prior estimates, indicating strong demand for GaN chips.

Market effects

Positive for the broader semiconductor and GaN chip sector.

U.S. tech stocks may see modest gains.

Limited to investors tracking semiconductor supply constraints.

Counterpoint

The rally could be short‑lived if capacity expansion fails to meet demand.

Key entities

  • Semtech Corp.

    U.S.-listed semiconductor manufacturer (ticker SMTC).

Related articles

$INTUHighAI 8/10

After-Hours Movers: INTU, SMTC, SYRE, ZM, NCNO

Intuit (INTU) fell 9% after lowering FY2027 guidance, missing EPS and revenue estimates. Semtech (SMTC) rose 3% on strong Q2 results and raised Q3 outlook. Spyre Therapeutics (SYRE) dropped 16% due to failed clinical trial results. Zoom (ZM) declined 3.5% despite Q2 beat, citing growth normalization. nCino (NCNO) fell 10% on near-term guidance concerns.

$NVDAMed

BMO starts chip stocks coverage: Here are its preferred picks

BMO Capital Markets initiated coverage of semiconductor and quantum computing sectors, favoring AI-exposed and analog chipmakers. Nvidia (top pick) received an Outperform rating and $340 target, with expected revenue growth of 84% and 50% in FY27 and 2028. Other picks include Broadcom, Micron, AMD, Marvell, Semtech, Analog Devices, Microchip, and Impinj. BMO predicts a memory market supercycle and AI-driven capex growth.

$SMTCMed

Why Is Semtech (SMTC) Stock Rocketing Higher Today

Semtech (SMTC) shares rose about 5.7% after Needham reiterated a Buy rating and set a $200 price target, citing strong demand and expectations for better performance in 2H 2026 and 2027. Drivers included improved 800G and 1.6T optical module shipments, CopperEdge ACC adoption by a major cloud customer, and LoRa+ wireless demand.

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher? — alphai